1. Home
  2. WLY vs VCEL Comparison

WLY vs VCEL Comparison

Compare WLY & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLY

John Wiley & Sons Inc.

SELL

Current Price

$52.67

Market Cap

2.4B

ML Signal

SELL

Logo Vericel Corporation

VCEL

Vericel Corporation

SELL

Current Price

$39.98

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WLY
VCEL
Founded
1807
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Books
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
WLY
VCEL
Price
$52.67
$39.98
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $59.71
AVG Volume (30 Days)
408.9K
★ 511.9K
Earning Date
12-03-2026
11-05-2026
Dividend Yield
★ 2.70%
N/A
EPS Growth
★ 171.90
60.00
EPS
N/A
★ N/A
Revenue
★ $1,796,103,000.00
$276,259,000.00
Revenue This Year
$4.68
$21.71
Revenue Next Year
$3.13
$16.86
P/E Ratio
N/A
★ N/A
Revenue Growth
4.51
★ 16.45
52 Week Low
$28.38
$28.95
52 Week High
$57.45
$49.32

Technical Indicators

Market Signals
Indicator
WLY
VCEL
Relative Strength Index (RSI) 61.34 48.55
Support Level $48.69 $37.78
Resistance Level $53.24 $41.21
Average True Range (ATR) 1.41 1.29
MACD 0.59 0.13
Stochastic Oscillator 77.99 47.50

Price Performance

Historical Comparison
WLY
VCEL

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning, which includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: